544.33
United Therapeutics Corp 주식(UTHR)의 최신 뉴스
Martine Rothblatt, United Therapeutics CEO, sells $5.1m in stock - Investing.com
Form 4 United Therapeutics Corporation For: 22 June By Investing.com - Investing.com Canada
Martine Rothblatt, United Therapeutics CEO, sells $5.1m in stock By Investing.com - Investing.com Canada
Q1 Earnings Outperformers: United Therapeutics (NASDAQ:UTHR) And The Rest Of The Therapeutics Stocks - StockStory
United Therapeutics EVP Mahon sells $4.5m in company stock - Investing.com UK
United Therapeutics EVP Mahon sells $4.5m in company stock By Investing.com - Investing.com South Africa
United Therapeutics StockThursday technical picture and trading levels - AD HOC NEWS
United Therapeutics Corp (UTHR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
United Therapeutics Corp (UTHR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
United Therapeutics CEO Rothblatt sells $5.2m in shares - Investing.com
United Therapeutics Corp (UTHR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
United Therapeutics' Liver Assist Product Earns FDA Regenerative Medicine Advanced Therapy Designation - Medical Product Outsourcing
United Therapeutics CFO Edgemond sells $5.49m in common stock By Investing.com - Investing.com India
United Therapeutics CFO Edgemond sells $5.49m in common stock - Investing.com
United Therapeutics Corp (UTHR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 21.85% Upside Potential - DirectorsTalk Interviews
MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Stocktwits
United Therapeutics CFO Edgemond sells $5.49m in company stock By Investing.com - Investing.com Nigeria
United Therapeutics CFO Edgemond sells $5.49m in company stock - Investing.com
Martine Rothblatt, United Therapeutics chairperson & CEO, sells $5.2m in stock By Investing.com - Investing.com South Africa
Martine Rothblatt, United Therapeutics chairperson & CEO, sells $5.2m in stock - Investing.com Nigeria
Neuroblastoma Market Gains Momentum with Expanding Pipeline and Investment Potential by 2034 – DelveInsight | Y-mAbs Therapeutics, United Therapeutics Corp, EUSA Pharma, Clarity Pharma, Eli Lilly - Barchart
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns - The Motley Fool
United Therapeutics CEO Rothblatt sells $5.2m in shares By Investing.com - Investing.com South Africa
United Therapeutics CFO James Edgemond sells $5.48m in stock - Investing.com
United Therapeutics CFO James Edgemond sells $5.48m in stock By Investing.com - Investing.com South Africa
Goodwin Advises Ascidian Therapeutics On A Global Research Collaboration With Eli Lilly For Up To $1.9 Billion - Mondaq
Martine Rothblatt, United Therapeutics CEO, sells $5.2m in stock By Investing.com - Investing.com South Africa
Martine Rothblatt, United Therapeutics CEO, sells $5.2m in stock - Investing.com
United Therapeutics Corporation (UTHR) Stock Analysis: Investor Outlook on Robust Growth Potential with 20.98% Upside - DirectorsTalk Interviews
United Therapeutics CEO Rothblatt sells $5.47m in stock - Investing.com
UTHRUnited Therapeutics Corp Stock Price and Quote - Finviz
Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report? - Yahoo Finance
How The Story Around United Therapeutics (UTHR) Is Shifting On Trials Pricing And Valuation - Yahoo Finance
MannKind develops inhaled ralinepag formulation for United Therapeutics - Investing.com
United Therapeutics EVP Mahon sells $4.54 million in stock - Investing.com UK
United Therapeutics Q1 2026 slides: IPF breakthrough offsets revenue miss - Investing.com
MannKind stock surges on United Therapeutics partnership deal - Investing.com
United Therapeutics EVP Mahon sells $4.54 million in stock By Investing.com - Investing.com Australia
자본화:
|
볼륨(24시간):